Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5′ AMP-activated protein kinase-Reference-Cited by-同舟云学术

Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5′ AMP-activated protein kinase

Published:2011-10 Issue:1 Volume:414 Page:53-59
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Adachi Seiji,Yasuda Ichiro,Kawaguchi Junji,Yamauchi Takahiro,Nakashima Masanori,Itani Masahiko,Nakamura Momoko,Yoshioka Takashi,Moriwaki Hisataka,Kozawa Osamu

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference22 articles.

1. Gemcitabine: preclinical pharmacology and mechanisms of action;Plunkett;Semin. Oncol.,1996

2. Advanced pancreatic carcinoma: current treatment and future challenges;Stathis;Nat. Rev. Clin. Oncol.,2010

3. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors;Marshall;Cancer,2006

4. Mechanisms for oncogenic activation of the epidermal growth factor receptor;Zandi;Cell. Signal.,2007

5. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1;Lahusen;Cancer Res.,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling;BANGL J PHARMACOL;2024

2. Tri-2-Hydroxyarachidonein Induces Cytocidal Autophagy in Pancreatic Ductal Adenocarcinoma Cancer Cell Models;Frontiers in Physiology;2022-01-20

3. Eupatilin Suppresses Pancreatic Cancer Cells via Glucose Uptake Inhibition, AMPK Activation, and Cell Cycle Arrest;Anticancer Research;2021-12-29

4. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells;The FASEB Journal;2019-01-31

5. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder;Current Drug Metabolism;2018-07-20